We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
-11.29%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$804M
AUM Growth
-$144M
Cap. Flow
-$27.2M
Cap. Flow %
-3.38%
Top 10 Hldgs %
21.56%
Holding
272
New
8
Increased
53
Reduced
127
Closed
24

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$7.85M
2
RTN
Raytheon Company
RTN
+$1.79M
3
V icon
Visa
V
+$1.77M
4
AMZN icon
Amazon
AMZN
+$1.65M
5
TMO icon
Thermo Fisher Scientific
TMO
+$820K

Sector Composition

Rank Sector Weight
1 Healthcare 17.54%
2 Technology 15.29%
3 Miscellaneous 13.75%
4 Industrials 10.97%
5 Financials 10.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EOG icon
76
EOG Resources
EOG
$80.6B
$2.96M 0.37%
33,957
+650
+2% +$69.6K
VTI icon
77
Vanguard Morningstar Total Stock Market ETF
VTI
$681B
$2.91M 0.36%
22,819
+842
+4% +$116K
CMCSA icon
78
Comcast
CMCSA
$86.7B
$2.79M 0.35%
81,797
-459
-0.6% -$16.8K
APD icon
79
Air Products & Chemicals
APD
$64.7B
$2.76M 0.34%
17,227
-1,763
-9% -$279K
DIS icon
80
Walt Disney
DIS
$184B
$2.74M 0.34%
25,007
-2,718
-10% -$309K
NSC icon
81
Norfolk Southern
NSC
$71.9B
$2.71M 0.34%
18,138
-10
-0.1% -$1.65K
IFF icon
82
International Flavors & Fragrances
IFF
$21.5B
$2.63M 0.33%
19,593
+69
+0.4% +$9.55K
GOOGL icon
83
Alphabet (Google) Class A
GOOGL
$4.22T
$2.58M 0.32%
49,300
+660
+1% +$35.7K
CL icon
84
Colgate-Palmolive
CL
$69.4B
$2.57M 0.32%
43,111
-6,786
-14% -$425K
WY icon
85
Weyerhaeuser
WY
$16.1B
$2.52M 0.31%
115,125
-39,171
-25% -$1.04M
PH icon
86
Parker-Hannifin
PH
$117B
$2.4M 0.3%
16,121
-125
-0.8% -$20.2K
WAB icon
87
Wabtec
WAB
$47B
$2.36M 0.29%
33,611
-5,365
-14% -$468K
VXUS icon
88
Vanguard Total International Stock ETF
VXUS
$162B
$2.36M 0.29%
49,965
-460
-0.9% -$22.9K
XBI icon
89
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$2.35M 0.29%
32,739
-3,267
-9% -$263K
SRCL
90
DELISTED
Stericycle Inc
SRCL
$2.31M 0.29%
63,095
-25,383
-29% -$1.19M
GLW icon
91
Corning
GLW
$124B
$2.31M 0.29%
76,537
+580
+0.8% +$18.5K
IBM icon
92
IBM
IBM
$234B
$2.23M 0.28%
20,566
-767
-4% -$92.1K
KMI icon
93
Kinder Morgan
KMI
$68.5B
$2.23M 0.28%
144,946
-51,402
-26% -$870K
FDX icon
94
FedEx
FDX
$73B
$2.2M 0.27%
13,622
+15
+0.1% +$3.17K
NVO
95
Novo Nordisk
NVO
$188B
$2.18M 0.27%
94,738
-880
-0.9% -$19.6K
BMY icon
96
Bristol-Myers Squibb
BMY
$130B
$2.15M 0.27%
41,392
-700
-2% -$37.6K
DD icon
97
DuPont de Nemours
DD
$17.3B
$2.15M 0.27%
15,851
+56
+0.4% +$8.04K
NVS icon
98
Novartis
NVS
$263B
$2.1M 0.26%
27,267
-2,305
-8% -$179K
AMGN icon
99
Amgen
AMGN
$203B
$2.08M 0.26%
10,661
+46
+0.4% +$8.97K
SSNC icon
100
SS&C Technologies
SSNC
$19.1B
$2.03M 0.25%
44,970
-775
-2% -$37.6K

Similar funds

Boston Family Office's Q4 2018 Portfolio in Review

As of Q4 2018, Boston Family Office held 272 positions worth $804M, down 15% from $949M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Boston Family Office withdrew a net $27.2M in Q4 2018, closing 24 positions and reducing 127 holdings. Its most notable exit was Praxair Inc, an estimated $8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Miscellaneous.

Against the trend, Boston Family Office opened a new position in Linde worth $7.75M.

  • Boston Family Office's largest Q4 2018 buy was Linde: 49,673 shares worth $7.75M.
  • Boston Family Office added most to Raytheon Company in Q4 2018, an estimated $1.79M increase.
  • Boston Family Office's biggest Q4 2018 reduction was TE Connectivity, cutting an estimated $2.36M.
  • Boston Family Office fully exited Praxair Inc in Q4 2018, selling an estimated $8M.
  • Boston Family Office's ten largest holdings make up 22% of its $804M portfolio in Q4 2018.
  • Boston Family Office opened 8 new positions and closed 24 in Q4 2018.
  • Boston Family Office's portfolio value fell 15% quarter-over-quarter to $804M.

Based on Boston Family Office's 13F filing for Q4 2018, filed 12 Feb 2019.